Back to Search
Start Over
Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Can Be the Best Therapeutic Option in Severely Immunocompromised Patients Depending on a Case-by-Case Assessment of the Benefit-to-Risk Ratio.
- Source :
-
Gastroenterology [Gastroenterology] 2024 Aug; Vol. 167 (3), pp. 627-628. Date of Electronic Publication: 2024 Apr 26. - Publication Year :
- 2024
- Subjects :
- Humans
Risk Assessment
Recurrence
Male
Female
Treatment Outcome
Middle Aged
Aged
Fecal Microbiota Transplantation adverse effects
Immunocompromised Host
Clostridium Infections therapy
Clostridium Infections diagnosis
Clostridium Infections microbiology
Clostridium Infections immunology
Clostridioides difficile
Subjects
Details
- Language :
- English
- ISSN :
- 1528-0012
- Volume :
- 167
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Gastroenterology
- Publication Type :
- Report
- Accession number :
- 38679396
- Full Text :
- https://doi.org/10.1053/j.gastro.2024.04.022